Somatostatin receptor 5 is critical for protecting intestinal barrier function in vivo and in vitro.

Yanni Li, Xiao Li, Chong Geng, Yaoyu Guo, Chunhui Wang

Molecular and cellular endocrinology 2021 Sep 15

filter terms:

Somatostatin receptor 5 (SSTR5) is involved in intestinal barrier protection during colitis through modulating tight junction (TJ) proteins, but the mechanisms of SSTR5 in TJ regulation are largely unknown. Therefore, the present study was designed to illuminate how SSTR5 modulated intestinal barrier function and TJ proteins. In this study, activation of SSTR5 by its special agonist L817,818 effectively ameliorated impaired intestinal barrier function in TNF-α-pretreated cells and mice with colitis. Restoration of intestinal barrier function was dependent on upregulation of claudin-4 and ZO-1. Suppression of SSTR5 signaling through specific siRNA or the antagonist BIM23056 markedly exacerbated TNF-α-induced claudin-4 and ZO-1 damage. L817,818 treatment markedly suppressed TNF-α-induced NF-κB p65 phosphorylation, myosin light chain kinase (MLCK) upregulation and myosin light chain (MLC) phosphorylation. Exposure to a NF-κB inhibitor (QNZ) or MLCK inhibitor (ML-7) effectively inhibited compromised claudin-4 and ZO-1 induced by BIM23056/TNF-α. These observations indicate that activation of SSTR5 protects intestinal barrier function by upregulating claudin-4 and ZO-1 expression, which is mediated by NF-κB-MLCK-MLC signaling. Taken together, our findings suggest that SSTR5 might represent a promising target for colitis therapy. Copyright © 2021 Elsevier B.V. All rights reserved.

Citation

Yanni Li, Xiao Li, Chong Geng, Yaoyu Guo, Chunhui Wang. Somatostatin receptor 5 is critical for protecting intestinal barrier function in vivo and in vitro. Molecular and cellular endocrinology. 2021 Sep 15;535:111390